Seeking Alpha

AstraZeneca (AZN) receives FDA approval for its BRILINTA tablets to reduce the rate of heart...

AstraZeneca (AZN) receives FDA approval for its BRILINTA tablets to reduce the rate of heart attack in adult patients with acute coronary syndrome. Shares +1.62% AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|